The latest market research report by IMARC Group, titled “US Healthcare Advertising Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the US healthcare advertising market reached a value of US$ 21.3 Billion in 2021. Looking forward, the market is anticipated to reach a value of US$ 28.1 Billion by 2027, at a projected CAGR of 4.81% over the forecast period of 2022-2027.

Healthcare advertising represents the process of developing communication and marketing strategies for reaching new patients by creating an open line of communication between them and healthcare organizations. It usually relies on highly segmented and targeted online as well as offline strategies to boost engagement and accelerate enterprise growth. In addition to this, healthcare advertising is used to spread awareness towards several diseases and the availability of advanced drugs and procedures across the US.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a Free PDF Sample of the Report: https://www.imarcgroup.com/us-healthcare-advertising-market/requestsample

US Healthcare Advertising Market Trends and Drivers:

The widespread adoption of various synchronized communication channels by pharmaceutical companies is primarily driving the US healthcare advertising market. Additionally, the increasing number of digital promotions, such as product websites, online display advertising, social media campaigns, etc., is further catalyzing the market growth. Besides this, the rising investments in advertising by healthcare organizations via television and print ads, the inflating popularity of generic and me-too drugs, the expanding geriatric population, and numerous technological advancements are acting as significant growth-inducing factors. Moreover, Google, one of the extensively used search engine, has allowed advertisers to post advertisements for human immunodeficiency virus (HIV) home tests, addiction services, prescription drug clinical trial recruitment, etc., which is propelling the market growth in this country. Apart from this, the introduction of telemedicine, electronic health records, and remote medical monitoring is anticipated to fuel the US healthcare advertising market over the forecasted period.

Market Summary:

• On the basis of product types, the US healthcare advertising market has been segmented into pharmaceuticals (small molecule drugs), biopharmaceuticals, vaccines and over-the-counter drugs. Amongst these, advertisements in the pharmaceuticals (small molecule drugs) market have witnessed a dramatic increase in the past few years.
• The competitive landscape of the market has also been examined in the report. Some of the key players operating in the industry include Johnson & Johnson, Pfizer, Merck & Co., GlaxoSmithKline, Eli Lilly, Novartis, Sanofi, AstraZeneca, Roche, Bayer HealthCare, and Bristol- Myers Squibb.

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=723&flag=C

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800